| 注册
首页|期刊导航|中国药物评价|青海省医疗机构中藏药制剂备案常见问题及分析

青海省医疗机构中藏药制剂备案常见问题及分析

石春兰 年永琪 汪永明 刘学良 程小平 王永晶 祁彦凯 韩达斌

中国药物评价2026,Vol.43Issue(2):86-89,4.
✕
中国药物评价2026,Vol.43Issue(2):86-89,4.

青海省医疗机构中藏药制剂备案常见问题及分析

Common Problems and Analysis of Tibetan Medicine Preparation Filing in Medical Institutions in Qinghai Province

石春兰 1年永琪 1汪永明 1刘学良 1程小平 1王永晶 1祁彦凯 1韩达斌1

作者信息

  • 1. 青海省药品审评核查中心,青海西宁 810000
  • 折叠

摘要

Abstract

Objective:To summarize and analyze the problems found in the preparation record data of ethnic medical institutions in our province,and to explore the possible solutions and ideas under the new situation of encouraging the development of ethnic medicine and ensuring the safety of public drug use,so as to provide reference for the formulation and introduction of guiding policies.Methods:The filing situation of Chinese and Tibetan medicine preparations declared in our province from 2018 to 2022 was investiga-ted,and the filing data of Chinese and Tibetan medicine preparations prepared by traditional technology in medical institutions were collected and analyzed.Results The declaration of preparations for medical institutions needs to be improved in terms of preparation name,functional indications,instructions,process and quality standard research.Conclusion:Medical institutions should strengthen the examination of the scientificity and necessity of the research and development of preparations,and carry out research based on the actual needs of clinical and patients;the regulatory authorities need to speed up the formulation of preparations with multi-unit records and large clinical dosage,and the quality standards of medicinal materials without national standards in the prescriptions,so as to promote the standardized development of preparations in ethnic medical institutions and prosper the cause of ethnic medicine.

关键词

医疗机构制剂/备案/中藏药制剂/传统工艺/申报资料

Key words

Medical institution preparations/Recording/Tibetan medicine preparations/Traditional crafts

分类

医药卫生

引用本文复制引用

石春兰,年永琪,汪永明,刘学良,程小平,王永晶,祁彦凯,韩达斌..青海省医疗机构中藏药制剂备案常见问题及分析[J].中国药物评价,2026,43(2):86-89,4.

基金项目

青海省基础研究项目(2025-ZJ-603) (2025-ZJ-603)

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文